This Article Full Text Full Text (PDF) All Versions of this Article: 38/6/1959    most recent STROKEAHA.106.480657v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Smolders, B. Articles by Thijs, V. Search for Related Content PubMed PubMed Citation Articles by Smolders, B. Articles by Thijs, V. Pubmed/NCBI databases Gene GEO Profiles HomoloGene UniGene Substance via MeSH Medline Plus Health Information Stroke Related Collections Genetics of Stroke Risk Factors for Stroke Lipid and lipoprotein metabolism

(Stroke. 2007;38:1959.)
© 2007 American Heart Association, Inc.

Comments, Opinions, and Reviews

Lipoprotein (a) and Stroke

A Meta-Analysis of Observational Studies

Barbara Smolders, MSc; Robin Lemmens, MD Vincent Thijs, MD, PhD

From Department of Clinical and Experimental Neurology, University Hospitals Leuven, Leuven, Belgium.

Correspondence to Vincent Thijs, Department of Neurology, University Hospitals Leuven, Herestraat 49, B3000 Leuven, Belgium. E-mail vincent.thijs{at}uzleuven.be

Background and Purpose— The relationship between elevated lipoprotein (a) levels[Lp(a)] and stroke is controversial. We systematically reviewed the literature to determine whether Lp(a) is a risk factor for stroke.

Methods— We searched MEDLINE (1966 to 2006), EMBASE (1974 to 2006), and Google scholar for articles on Lp(a) and cerebrovascular disease. From potentially relevant references retrieved, we excluded uncontrolled studies, studies of children with stroke, studies investigating carotid atherosclerosis, and studies lacking adequate data.

Results— Thirty-one studies comprising 56 010 subjects with >4609 stroke events met all inclusion criteria and were included in the meta-analysis. In case-control studies (n=23 with 2600 strokes) unadjusted mean Lp(a) was higher in stroke patients (standardized mean difference, 0.39; 95% CI, 0.23 to 0.54) and was more frequently abnormally elevated (OR, 2.39; 95% CI, 1.57 to 3.63). Sensitivity analysis and meta-regression did not find any influence of study design, measurement period of Lp(a) in relationship to stroke episode, subtype, age, and sex to explain the substantial heterogeneity between studies (I²=83.7%; P<0.001). There was no evidence of publication bias. In nested case-control studies (n=3 with 364 strokes) Lp(a) was not a risk factor for incident stroke (OR, 1.04; 95% CI, 0.6 to 1.8). In prospective cohort studies (n=5 with >1645 strokes), incident stroke was more frequent in patients in the highest tertile of Lp(a) distribution compared with the lowest tertile of Lp(a) (RR, 1.22; 95% CI, 1.04 to 1.43). There was no publication bias or heterogeneity in the prospective studies (I²=0.00%; P=0.67).

Conclusion— This meta-analysis suggests that elevated Lp(a) is a risk factor for incident stroke.

Key Words: lipids • meta-analysis • risk factors • stroke

This article has been cited by other articles:

				H. Takagi, H. Manabe, N. Kawai, S.-n. Goto, and T. Umemoto Circulating lipoprotein(a) concentrations and abdominal aortic aneurysm presence Interactive CardioVascular and Thoracic Surgery, September 1, 2009; 9(3): 467 - 470. [Abstract] [Full Text] [PDF]

				The Emerging Risk Factors Collaboration Lipoprotein(a) Concentration and the Risk of Coronary Heart Disease, Stroke, and Nonvascular Mortality JAMA, July 22, 2009; 302(4): 412 - 423. [Abstract] [Full Text] [PDF]

				M. Knoflach, S. Kiechl, D. Penz, A. Zangerle, C. Schmidauer, A. Rossmann, M. Shingh, R. Spallek, A. Griesmacher, D. Bernhard, et al. Cardiovascular Risk Factors and Atherosclerosis in Young Women: Atherosclerosis Risk Factors in Female Youngsters (ARFY Study) Stroke, April 1, 2009; 40(4): 1063 - 1069. [Abstract] [Full Text] [PDF]